Mayo Clinic doctors were the first to publish a report on the link between the insomnia drug zolpidem (Ambien) and sleep-related eating disorders. They continue research on a range of disruptive sleep-related disorders.
See a list of publications by Mayo Clinic doctors on sleep-related eating disorder on PubMed, a service of the National Library of Medicine.
Apr. 15, 2014
- Howell MJ. Parasomnias: An updated review. Neurotherapeutics. 2012;9:763.
- Antelmi E, et al. Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index. Sleep Medicine. In press. Accessed Jan. 9, 2014.
- Women and sleep. National Sleep Foundation. http://www.sleepfoundation.org/article/sleep-topics/women-and-sleep. Accessed Jan. 9, 2014.
- Howell MJ. Restless eating, restless legs, and sleep related eating disorder. Current Obesity Reports. Dec. 19, 2013. http://link.springer.com/article/10.1007/s13679-013-0083-6. Accessed Jan. 10, 2013.
- Silber MH (expert opinion). Mayo Clinic, Rochester, Minn. Jan. 28, 2014.
- Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist). U.S. Food and Drug Administration http://www.fda.gov/Drugs/DrugSafety/ucm334041.htm#q8. Accessed Feb. 1, 2014.